Why Revolution Medicines, Inc. (RVMD) stock moved
Revolution Medicines, Inc. (RVMD) shares tumbled 6.3% to $188.12 as of October 8, 2026, a significant decline from the prior close of $200.87. BestStocks flagged the session as a major change for RVMD. Below, we break down what changed for RVMD, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
RVMD fell 6.3% to $188.12
Revolution Medicines fell 6.19% to $188.43 as investors engaged in profit-taking on high-flying biotech stocks amid technical weakness and recent insider selling disclosures, according to web sources tracking the October 8 session. The decline occurred despite the company's announcement of patient enrollment in its Phase 3 RASolute 309 trial for metastatic pancreatic cancer, suggesting the positive operational update was overshadowed by sector-wide valuation digestion following a sustained multi-month rally. RVMD earnings on November 4, 2026 (consensus EPS estimate: –$2.35); monitor for any updates on RASolute 309 enrollment pace and management commentary on insider transactions.
What it means for Revolution Medicines, Inc. investors
For Revolution Medicines, Inc. investors, the recent signals add up to a strong bearish shift. On the constructive side: Revolution Medicines, Inc. (RVMD) moved +5.79% from $182.08 to $192.62 on 2026-06-29, reaching a new 30-day high. Weighing against that: Material negative event; Sharp 6.3% decline — elevated risk. Wall Street's consensus price target sits at $253.35, implying +34.7% upside from $188.12. BestStocks rates the overall signal quality medium (68/100). With earnings roughly 27 days out, the next report is the most likely near-term test of the move.
RVMD price reaction
RVMD last traded at $188.12, down $12.75 (-6.35%) from the previous close of $200.87. The session traded on 2.1× average volume (very high), so the move carried above-average conviction. Over the past month the stock has ranged between $188.12 and $207.68, and it currently sits about 0% of the way up that band.
Bullish and bearish analyst opinions on Revolution Medicines, Inc. (RVMD)
The consensus analyst price target on Revolution Medicines, Inc. (RVMD) is $253.35, 34.7% above the recent $188.12. Over the past 90 days analysts logged 0 upgrades, 21 maintains, and 0 downgrades. Here is how the bullish and bearish cases on RVMD line up.
The bullish case
- Wall Street's consensus price target of $253.35 implies +34.7% upside from $188.12.
- The Street's most bullish target is $320.00 (+70.1%).
- Revolution Medicines, Inc. (RVMD) moved +5.79% from $182.08 to $192.62 on 2026-06-29, reaching a new 30-day high.
The bearish case
- The most bearish analyst target is $179.00 (-4.8%).
- Material negative event.
- Sharp 6.3% decline — elevated risk.
- High volume 2.1x on decline — distribution signal.
- Revolution Medicines shares fell 4.18% to $196.30, driven by a combination of profit-taking following the FDA's recent Breakthrough Therapy Designation for pancreatic cancer drug Rasonque, plus insider selling pressure.
Weighing both sides, BestStocks' composite read of recent signals is strongly bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Oct 8, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for RVMD
In-depth RVMD event analyses
Frequently asked questions about RVMD
Why did Revolution Medicines, Inc. (RVMD) stock move?
RVMD tumbled 6.3% to $188.12. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.
How much did RVMD stock fall?
RVMD lost 6.35% ($12.75) versus the prior close of $200.87, last trading at $188.12 on 2.1× average volume.
When is Revolution Medicines, Inc.'s next earnings date?
RVMD's next earnings report is estimated for 2026-11-04 — about 27 days away.
What is the analyst price target for RVMD?
The consensus analyst price target for RVMD is $253.35, about 34.7% above the current $188.12. Over the past 90 days, analysts recorded 0 upgrades, 21 maintains, and 0 downgrades.
How BestStocks tracks RVMD
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared RVMD-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for RVMD, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of October 8, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.